Discovery and Optimization of N‑Heteroaryl Indazole LRRK2 Inhibitors.

MLA

Logan, Kaitlyn M., et al. “Discovery and Optimization of N‑Heteroaryl Indazole LRRK2 Inhibitors.” Journal of Medicinal Chemistry, vol. 67, no. 18, Sept. 2024, pp. 16807–19. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.4c01627.

APA

Logan, K. M., Kaplan, W., Simov, V., Zhou, H., Li, D., Torres, L., Morriello, G. J., Acton, J. J., Pio, B., Chen, Y.-H., Keylor, M. H., Johnson, R., Kattar, S. D., Chau, R., Yan, X., Ardolino, M., Zarate, C., Otte, K. M., Palte, R. L., & Xiong, T. (2024). Discovery and Optimization of N‑Heteroaryl Indazole LRRK2 Inhibitors. Journal of Medicinal Chemistry, 67(18), 16807–16819. https://doi.org/10.1021/acs.jmedchem.4c01627

Chicago

Logan, Kaitlyn M., Will Kaplan, Vladimir Simov, Hua Zhou, Derun Li, Luis Torres, Gregori J. Morriello, et al. 2024. “Discovery and Optimization of N‑Heteroaryl Indazole LRRK2 Inhibitors.” Journal of Medicinal Chemistry 67 (18): 16807–19. doi:10.1021/acs.jmedchem.4c01627.